Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (A60217) - R1 - Effective October 1, 2026

Date Posted: September 24, 2026

This Billing and Coding Article has been revised under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: October 1, 2026

Summary of Changes:

Under ICD-10 Codes that Support Medical Necessity Group 1: Codes added K74.0A. This revision is due to the Annual ICD-10-CM Code Update and will become effective 10/1/2026.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated Sep 24 , 2026